Diabetes Management Technologies 2022-2032: Markets, Players, and Forecasts: IDTechEx
Insulin Pumps Edge Injections for T1D Glycemic Control
Safety and Effectiveness of an Investigational Insulin Delivery Device Providing Basal/Bolus Therapy with Rapid-Acting or Regular Human Insulin in Adults with Type 2 Diabetes | Diabetes Technology & Therapeutics
Abbott FreeStyle Libre app pairs with Novo Nordisk insulin pens
EU Approves Novo Nordisk's Pre-filled Insulin Cartridge for the New Accu-Chek Insight Insulin Pump
Patient-reported outcomes for 2,335 adults with type 2 diabetes using the Omnipod® Insulin Management System show glycaemic improvement over the first 90 days of use - Media Centre | EASD
Insulet gives go-ahead for more TV ads, prepping for Omnipod 5 launch later this year | Fierce Pharma
In milestone trial, experimental drug delays type 1 diabetes | Science | AAAS
New closed-loop insulin systems | SpringerLink
With new Medtronic pact, Novo Nordisk's smart insulin pen to link with all major CGMs | Fierce Biotech
Integrated Insulin Pump and Continuous Glucose Monitoring Technology in Diabetes Care Today: A Perspective of Real-Life Experience With the Minimed™ 670G Hybrid Closed-Loop System - Endocrine Practice
Combination of Novo Nordisk's Insulin degludec and Victoza Provides Synergistic Benefits in Late-Stage Trial
Fully closed-loop insulin delivery in inpatients receiving nutritional support: a two-centre, open-label, randomised controlled trial - The Lancet Diabetes & Endocrinology
Treating Type 2 Diabetes | Medtronic
FDA OKs Novo Nordisk's Fiasp for infusion pumps - MassDevice
Novo Nordisk's Rybelsus launch defies 2020 full-year sales expectations, despite the economic impacts of the Covid-19 pandemic - Pharmaceutical Technology
Insulin 100 years
New Diabetes Technology: What to Expect in 2021
New Diabetes Technology: What to Expect in 2021
Time for a new pump? Don't wait for... - Tandem Diabetes Care | Facebook
Hybrid Closed Loop Comparisons & Options for controlling diabetes
Ozempic 2mg Dose Approved to Provide Additional Glycemic Control in Type 2 Diabetes - MPR
Glooko Announces Collaboration with Novo Nordisk for European Connected Pen Launches - Glooko
